Stratasys and New York University Exploring 3D Printing as Prostate Surgery Tool

Stratasys and New York University Exploring 3D Printing as Prostate Surgery Tool
The tech company Stratasys has joined New York University School of Medicine researchers in a clinical trial looking at whether 3D printing can help diagnose and treat prostate and kidney cancer. Researchers want to know if 3D models of patients' organs and disorders can increase the accuracy of the plans surgeons put together before operating, make the surgery more precise, and improve surgical outcomes. The team is using a Stratasys J750 3D printer to make multi-colored models of patients' tumors. The company develops technology for a number of industries, including medicine. Nicole Wake, a researcher at the medical school's Sackler Institute of Graduate Biomedical Sciences, is leading the 3D printing project. Her team is printing 3D kidney and prostate cancer models for 300 patients, then assessing whether the models can do a better job than two-dimensional visuals at helping surgeons plan operations. By producing models in different colors, textures, and transparencies, researchers can better replicate the look, feel and function of organs ranging from soft tissue to bones. “3D printing holds a lot of potential in assisting with surgical planning, and as surgeons, we are always looking at ways to improve outcomes for our patients,” Dr. William C. Huang, a co-author of the study, said in a press release. “We are pleased to be leading a study examining how 3D-printed models may improve the surgical planning process and ultimately impact patient care.” “Surgeons and hospitals c
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *